ARTICLE | Company News
Abbott sales and marketing update
October 1, 2012 7:00 AM UTC
Abbott launched the Absorb bioresorbable vascular scaffold in Europe and parts of Asia-Pacific and Latin America to treat coronary artery disease (CAD). The everolimus-eluting bioabsorbable scaffold ...